Detalhe da pesquisa
1.
Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers.
PLoS Comput Biol
; 20(3): e1011238, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466770
2.
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
J Hepatol
; 80(6): 882-891, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340811
3.
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.
Gut
; 72(5): 972-983, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707234
4.
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
J Hepatol
; 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36931396
5.
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
J Hepatol
; 79(5): 1129-1138, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459920
6.
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.
Gut
; 71(2): 372-381, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509930
7.
Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.
Hepatology
; 72(3): 829-844, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925967
8.
Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.
Liver Int
; 41(2): 410-419, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997847
9.
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
BMC Gastroenterol
; 20(1): 24, 2020 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000689
10.
Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected Hepatocytes.
J Infect Dis
; 220(4): 567-577, 2019 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923817
11.
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo.
Gut
; 68(1): 150-157, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217749
12.
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Gastroenterology
; 154(3): 652-662.e8, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079518
13.
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
Gastroenterology
; 155(1): 180-193.e6, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550589
14.
Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
Gastroenterology
; 155(5): 1366-1371.e3, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30031767
15.
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
Gut
; 67(3): 542-552, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428345
16.
A novel orally available small molecule that inhibits hepatitis B virus expression.
J Hepatol
; 68(3): 412-420, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079285
17.
The hepatitis delta virus and chronic hepatitis D.
J Hepatol
; 77(5): 1448-1450, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850738
18.
Haem oxygenase-1 polymorphisms can affect HCV replication and treatment responses with different efficacy in humanized mice.
Liver Int
; 37(8): 1128-1137, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27992676
19.
Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.
Clin Infect Dis
; 62 Suppl 4: S281-8, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27190317
20.
Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.
J Hepatol
; 64(1 Suppl): S17-S31, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084033